a-collection-of-research-articles-on-the-medical-potential-of-cow-urine
a-collection-of-research-articles-on-the-medical-potential-of-cow-urine a-collection-of-research-articles-on-the-medical-potential-of-cow-urine
ISSN NO 2320-5407 International Journal
ISSN NO 2320-5407 International Journal
- Page 1 and 2: Raad et al., IJPSR, 2013; Vol. 4(4)
- Page 3 and 4: Raad et al., IJPSR, 2013; Vol. 4(4)
- Page 5 and 6: Raad et al., IJPSR, 2013; Vol. 4(4)
- Page 7 and 8: Pharmaceutical Biology ISSN: 1388-0
- Page 9 and 10: 790 E.E. Jarald et al. Downloaded b
- Page 11 and 12: 792 E.E. Jarald et al. Downloaded b
- Page 13 and 14: Global J. Pharmacol., 4 (1): 41-44,
- Page 15 and 16: Global J. Pharmacol., 4 (1): 41-44,
- Page 17 and 18: Randhawa and Sharma: Chemotherapeut
- Page 19 and 20: Randhawa and Sharma: Chemotherapeut
- Page 21 and 22: Randhawa and Sharma: Chemotherapeut
- Page 23 and 24: Mol Biol Rep (2014) 41:1967-1976 DO
- Page 25 and 26: Mol Biol Rep (2014) 41:1967-1976 19
- Page 27 and 28: Mol Biol Rep (2014) 41:1967-1976 19
- Page 29 and 30: Mol Biol Rep (2014) 41:1967-1976 19
- Page 31 and 32: Mol Biol Rep (2014) 41:1967-1976 19
- Page 33 and 34: ISSN NO 2320-5407 International Jou
- Page 35 and 36: ISSN NO 2320-5407 International Jou
- Page 37: ISSN NO 2320-5407 International Jou
- Page 41 and 42: Original Research Paper Lipid-lower
- Page 43 and 44: Chawda Hiren et al. Methodology
- Page 45 and 46: Chawda Hiren et al. Table 2. The
- Page 47 and 48: Chawda Hiren et al. Table 4. Eff
- Page 49 and 50: Chawda Hiren et al. References
ISSN NO 2320-5407 Internati<strong>on</strong>al Journal <str<strong>on</strong>g>of</str<strong>on</strong>g> Advanced Research (2013), Volume 1, Issue 5, 71-78<br />
G+CUD 4.52±0.84 4.56±0.49 4.61±0.66* 4.67±0.95* 4.77±0.48 4.80±0.20 4.73±0.79** 4.62±0.23 4.60±0.95* 4.68±0.44 4.98±0.67 5.00±0.24* 5.01±0.29*<br />
H+CUD 4.50±0.85* 4.54±0.81* 4.56±0.29 4.61±0.40 4.70±0.66* 4.75±0.25 4.67±0.90 4.61±0.50* 4.53±0.65 4.51±0.73 4.72±0.49** 4.95±0.32 4.96±0.12<br />
Table 6: Haemoglobin c<strong>on</strong>tent (Hb) <str<strong>on</strong>g>of</str<strong>on</strong>g> experimental mice at regular interval <str<strong>on</strong>g>of</str<strong>on</strong>g> 15 days (gm%, mean±SE).<br />
Groups/Days 0 15 30 45 60 75 90 105 120 135 150 165 180<br />
C<strong>on</strong>trol 12.45±1.42 12.47±1.51 12.53±1.52 12.51±1.42 12.55±1.47 12.50±1.44 12.52±1.41 12.55±1.37 12.56±1.35 12.58±1.39 12.62±1.34 12.66±1.21 12.68±1.36<br />
CUD(NO<br />
DEN)<br />
12.19±1.31* 12.21±1.42 12.27±1.51* 12.49±1.36 12.62±1.47* 12.85±1.51 12.99±1.62* 13.41±1.73* 13.53±1.81* 13.66±1.74* 13.70±1.32 13.76±1.21* 13.78±1.19<br />
DEN 12.40±1.36* 12.42±1.38 12.43±1.29 12.45±1.31** 12.46±1.33 12.25±1.36* 12.08±1.39 11.82±1.36* 11.65±1.30 10.52±1.32* 10.09±1.21 9.36±1.19* 8.02±1.07<br />
CUD 12.32±1.31 12.45±1.28** 12.86±1.33 12.90±1.37 13.06±1.29* 13.40±1.42 13.87±1.47 13.67±1.40* 13.46±1.33** 13.22±1.28* 12.79±1.21*<br />
12.09±1.19**<br />
12.34±1.28<br />
A 12.27±1.17** 12.43±1.27 12.84±1.29 12.87±1.32* 13.07±1.33 13.38±1.38* 13.85±1.41 14.04±1.43 13.95±1.47 13.80±1.27 13.76±1.23* 13.71±1.19 13.63±1.13<br />
B 12.31±1.40 12.39±1.35* 12.79±1.25 12.83±1.38** 13.03±1.27 13.30±1.30 13.79±1.37** 14.02±1.39* 13.95±1.41* 13.75±1.26 13.71±1.19** 13.67±1.21** 13.56±1.18<br />
G 12.34±1.28* 12.37±1.21 12.72±1.24** 12.79±1.41 13.04±1.32** 13.25±1.19** 13.72±1.29 13.96±1.26 13.91±1.25* 13.70±1.32* 13.65±1.27 13.61±1.21 13.49±1.29<br />
H 12.34±1.42 12.36±1.40 12.68±1.23** 12.74±1.21 12.95±1.31* 13.10±1.22 13.67±1.28 13.87±1.27 13.82±1.30 13.65±1.33* 13.59±1.24** 13.55±1.32* 13.40±1.25<br />
A+CUD 12.41±1.48* 12.48±1.47 12.89±1.36** 12.94±1.39 13.08±1.33* 13.42±1.41* 13.89±1.52* 14.06±1.47** 14.64±1.37 14.82±1.42 15.07±1.37 15.21±1.27 15.38±1.31*<br />
B+CUD 12.29±1.42* 12.40±1.37 12.81±1.27 12.85±1.36** 13.05±1.31 13.35±1.32 13.81±1.39 14.01±1.41 14.22±1.42 14.48±1.25 14.74±1.21* 14.89±1.22* 14.90±1.17*<br />
G+CUD 12.27±1.41 12.36±1.39** 12.76±1.21 12.80±1.29* 13.01±1.25 13.27±1.28 13.76±1.31* 13.98±1.30* 14.03±1.27* 14.33±1.21** 14.69±1.23 14.74±1.17 14.86±1.14<br />
H+CUD 12.30±1.39* 12.35±1.35 12.70±1.27* 12.76±1.23 12.98±1.33** 13.12±1.29* 13.70±1.20 13.90±1.24 13.97±1.26 14.08±1.31 14.62±1.28* 14.70±1.22 14.78±1.11**<br />
Significant difference in comparis<strong>on</strong> to c<strong>on</strong>trol (*p≤0.5 and **p≤0.01)<br />
Data <str<strong>on</strong>g>of</str<strong>on</strong>g> Hemoglobin is expressed in gm% and is<br />
presented in Table-6. Initially <strong>the</strong> Hb c<strong>on</strong>tent <str<strong>on</strong>g>of</str<strong>on</strong>g><br />
c<strong>on</strong>trol was 12.45±1.42gm% and after 6 m<strong>on</strong>th <strong>the</strong><br />
Hb c<strong>on</strong>tent <str<strong>on</strong>g>of</str<strong>on</strong>g> mice was 12.68±1.36gm%. In DEN<br />
(negative c<strong>on</strong>trol) group <strong>the</strong> initial Hb c<strong>on</strong>tent at zero<br />
day <str<strong>on</strong>g>of</str<strong>on</strong>g> experiment was 12.40±1.36gm%, which<br />
decreased to 8.02±1.07gm%, at <strong>the</strong> end <str<strong>on</strong>g>of</str<strong>on</strong>g><br />
experiment. But in CUD treated group, <strong>the</strong>ir Hb<br />
c<strong>on</strong>tent at zero day was 12.19±1.31gm% and<br />
13.78±1.19gm% at <strong>the</strong> end <str<strong>on</strong>g>of</str<strong>on</strong>g> experiment. In CUD<br />
treated group in which <strong>the</strong> carcinogen has been given,<br />
<strong>the</strong> initial Hb c<strong>on</strong>tent at zero day was<br />
12.32±1.31gm%, after <strong>the</strong> end <str<strong>on</strong>g>of</str<strong>on</strong>g> experiment <strong>the</strong> Hb<br />
c<strong>on</strong>tent was 12.09±1.19gm%. In test group A, <strong>the</strong><br />
zero day Hb c<strong>on</strong>tent was 12.27±1.17gm%. The Hb<br />
c<strong>on</strong>tent increased to 13.63±1.13gm% at <strong>the</strong> end <str<strong>on</strong>g>of</str<strong>on</strong>g><br />
experiment. In group B, G and H, <strong>the</strong> Hb c<strong>on</strong>tent at<br />
zero day was found 12.31±1.40gm%,<br />
12.34±1.28gm% and 12.34±1.42gm%, respectively<br />
and at <strong>the</strong> end <str<strong>on</strong>g>of</str<strong>on</strong>g> experiment <strong>the</strong> Hb c<strong>on</strong>tent reached<br />
to 13.56±1.18gm%, 13.49±1.29gm% and<br />
13.40±1.25gm%, respectivelyCUD+A had Hb<br />
c<strong>on</strong>tent at zero day 12.41±1.48gm% which was<br />
increased to 15.38±1.31gm%, at <strong>the</strong> end <str<strong>on</strong>g>of</str<strong>on</strong>g><br />
experiment. Group CUD+B had 12.29±1.42gm% Hb<br />
c<strong>on</strong>tent <strong>on</strong> zero day which was increased to<br />
14.90±1.17gm% at <strong>the</strong> end <str<strong>on</strong>g>of</str<strong>on</strong>g> experiment. In<br />
CUD+G and CUD+H, <strong>the</strong> Hb c<strong>on</strong>tent at zero day was<br />
12.27±1.41gm%, 12.30±1.39gm% and was<br />
14.86±1.14gm% and 14.78±1.11gm% at <strong>the</strong> end <str<strong>on</strong>g>of</str<strong>on</strong>g><br />
<strong>the</strong> experiment, respectively.<br />
Total Leucocyte count (TLC) in experimental mice<br />
76